Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929916 · ClinicalTrials.gov registry record
Comparing Two Different Ways to Take MoviPrep® Before Colonoscopy
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 125
- Enrollment target
NCT00929916: Completed study, sponsored by Thomas Jefferson University.
NCT00929916 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00929916 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
This study will evaluate whether morning-only dosing of MoviPrep® (2L) for afternoon colonoscopy is as effective as a standard dosing regimen of half of the volume of MoviPrep® (1L) solution the evening prior, and half (1L) the morning of, colonoscopy. MoviPrep® is a low volume (2 liters) polyethylene glycol (PEG)-based purgative that is approved for evening-only or split (evening and morning) dosing to cleanse the colon prior to colonoscopy. Patients undergoing afternoon colonoscopies often have inferior colon cleansing. There is evidence that morning-only purgative administration of large volume PEG (4L) is safe and effective. This study will assess whether administration of a low volume PEG regimen will maintain efficacy and improve tolerance by changing a 2-day preparation procedure into a regimen that is completed in 1 day.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-04 |
What the finished NCT00929916 record still lists
NCT00929916 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00929916 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00929916 about?
NCT00929916 is a clinical study titled "Comparing Two Different Ways to Take MoviPrep® Before Colonoscopy". This study will evaluate whether morning-only dosing of MoviPrep® (2L) for afternoon colonoscopy is as effective as a standard dosing regimen of half of the volume of MoviPrep® (1L) solution the evening prior, and half (1L) the morning of, colonoscopy. MoviPrep® is a low volume (2 liters) polyethyle...
What is the current status of trial NCT00929916?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2008-12. Estimated completion is 2009-04.
Who is sponsoring clinical trial NCT00929916?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia